Neurimmune

Developer of antibody therapeutics for the treatment neurodegenerative diseases

placeSchlieren, Zurich, Switzerland calendar_todayFounded 2006 groups82 employees language neurimmune.com

Registered entities

Social engagement

Social engagement: 5.9K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Biogen.

Investor typeCountShare
Other / undisclosed2100%

Recent activity

18 Mar 2026
Event
ADPD2026
4 Dec 2025
Partnership
Alexion Pharmaceuticals, Inc.
26 Aug 2025
Event
ESC Congress 2025
Coming soon